Laaboub, Nermine
Ranjbar, Setareh
Strippoli, Marie-Pierre F.
Marques-Vidal, Pedro
Estoppey-Younes, Sandrine
Ponte, Belen
Pruijm, Menno
Vogt, Bruno
Ansermot, Nicolas
Crettol, Séverine
Vandenberghe, Frederik
Vollenweider, Peter
Preisig, Martin
Bochud, Murielle
EAP, Chin B.
Funding for this research was provided by:
University of Lausanne
Article History
Received: 7 February 2023
Accepted: 9 February 2024
First Online: 4 May 2024
Declarations
:
: This study was carried out in accordance with the Declaration of Helsinki, the Swiss law, and local requirements. The studies protocols was approved by the Ethics committees of Vaud (SKIPOGH1 (Protocol number 92/07), SKIPOGH2 (303/12) and CoLaus|PsyCoLaus (16/03 and 33/09)), and Bern (SKIPOGH1 (091/09) and SKIPOGH2 (015/13), and Geneva (SKIPOGH1 (09–089) and SKIPOGH2 (12–286)) with participants giving a written informed consent.
: CBE received honoraria for conferences from Forum pour la formation médicale, Janssen-Cilag, Lundbeck, Otsuka, Sandoz, Servier, Sunovion, Sysmex Suisse AG, Vifor-Pharma, and Zeller in the past 3 years. NA received in the past 3 years honoraria for a conference from Sysmex Suisse AG. FV received in the past 3 years honoraria for conferences or teaching CME courses from Forum für MedizinischeFortbildung and Sysmex Suisse AG. SC received in the past 3 years honoraria for teaching CME courses from Forum pour la formation médicale, Barr Switzerland and for consultancy from the Swiss Health Observatory (Obsan) of the Swiss Federal Office of Public Health. MeP received in the past three years honoraria for conferences from Antaros Medical, Novo Nordisk, Astellas, and Vifor-Pharma and BBraun, and for consultancy from Boehringer Ingelheim and Baxter. All authors declare that they have no conflict of interest in relation to the content of this paper.